Chang KP - Search Results

1

Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?

Chang KP, Reynolds JM, Liu Y, He JJ. Chang KP, et al. Vaccines (Basel). 2022 Feb 7;10(2):248. doi: 10.3390/vaccines10020248. Vaccines (Basel). 2022. PMID: 35214706 Free PMC article. Review.

2

Leishmania and Leishmaniasis Research: The Past 50 Years and the Future.

Chang KP. Chang KP. Pathogens. 2023 May 30;12(6):776. doi: 10.3390/pathogens12060776. Pathogens. 2023. PMID: 37375466 Free PMC article.

3

From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis.

Costa CHN, Chang KP, Costa DL, Cunha FVM. Costa CHN, et al. Among authors: chang kp. Pathogens. 2023 Jul 24;12(7):969. doi: 10.3390/pathogens12070969. Pathogens. 2023. PMID: 37513817 Free PMC article. Review.

4

Evidence of a conserved mammalian immunosuppression mechanism in Lutzomyia longipalpis upon infection with Leishmania.

Telleria EL, Tinoco-Nunes B, Forrest DM, Di-Blasi T, Leštinová T, Chang KP, Volf P, Pitaluga AN, Traub-Csekö YM. Telleria EL, et al. Among authors: chang kp. Front Immunol. 2023 Nov 2;14:1162596. doi: 10.3389/fimmu.2023.1162596. eCollection 2023. Front Immunol. 2023. PMID: 38022562 Free PMC article.

5

Vaccination for Disease Prevention and Control: the Necessity of Renewed Emphasis and New Approaches.

Chang KP. Chang KP. J Immunol Immunotech. 2014;1(1):10.17653/2374-9105.SSe0001. doi: 10.17653/2374-9105.SSe0001. Epub 2014 Jul 9. J Immunol Immunotech. 2014. PMID: 27840849 Free PMC article. No abstract available.

6

Visceral Leishmaniasis in China: an Endemic Disease under Control.

Lun ZR, Wu MS, Chen YF, Wang JY, Zhou XN, Liao LF, Chen JP, Chow LM, Chang KP. Lun ZR, et al. Among authors: chang kp. Clin Microbiol Rev. 2015 Oct;28(4):987-1004. doi: 10.1128/CMR.00080-14. Clin Microbiol Rev. 2015. PMID: 26354822 Free PMC article. Review.

7

The prognostic value of lymph node to primary tumor standardized uptake value ratio in cancer patients: a meta-analysis.

Yap WK, Hsu KH, Wang TH, Lin CH, Kang CJ, Huang SM, Lin HC, Hung TM, Chang KP, Tsai TY. Yap WK, et al. Among authors: chang kp. Ann Nucl Med. 2024 May 9. doi: 10.1007/s12149-024-01933-5. Online ahead of print. Ann Nucl Med. 2024. PMID: 38724805

8

Growth Patterns of Prostate Cancers Undetected by Prostate 3T Multiparametric MRI.

Chang KP, Hsieh PF, Lin WC, Chang H. Chang KP, et al. In Vivo. 2024 Mar-Apr;38(2):833-841. doi: 10.21873/invivo.13508. In Vivo. 2024. PMID: 38418107 Free PMC article.

9

MiR-630 Promotes Radioresistance by Induction of Anti-Apoptotic Effect via Nrf2-GPX2 Molecular Axis in Head-Neck Cancer.

You GR, Cheng AJ, Shen EY, Fan KH, Huang YF, Huang YC, Chang KP, Chang JT. You GR, et al. Among authors: chang kp. Cells. 2023 Dec 17;12(24):2853. doi: 10.3390/cells12242853. Cells. 2023. PMID: 38132173 Free PMC article.

10

Comparison between a novel salivary marker and several clinical prognosticators in oral cavity cancer.

Lee YC, Lee LY, Huang Y, Kao HK, Chang YT, Hung SY, Lu CY, Chang YS, Yu JS, Chang KP. Lee YC, et al. Among authors: chang kp. Laryngoscope Investig Otolaryngol. 2023 Oct 12;8(6):1547-1556. doi: 10.1002/lio2.1166. eCollection 2023 Dec. Laryngoscope Investig Otolaryngol. 2023. PMID: 38130271 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

602 results

Search Page